Eqis Capital Management, Inc. Athersys, Inc Transaction History

Eqis Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.18 - $0.86 $19,156 - $91,526	106,426 Added 605.93%	123,990 $32,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $628 - $1,110	-1,048 Reduced 5.63%	17,564 $11,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $334 - $551	-394 Reduced 2.07%	18,612 $17,000
Q3 2021 Nov 12, 2021	SELL	$1.33 - $1.77 $787 - $1,047	-592 Reduced 3.02%	19,006 $25,000
Q2 2021 Aug 12, 2021	BUY	$1.41 - $1.94 $27,633 - $38,020	19,598 New	19,598 $28,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.